Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07385014 · ClinicalTrials.gov registry record · NA
Multicenter, Double-arm, Patient AND Assessor-masked, Prospective, Randomized Clinical Trial TO Compare Visual Performance OF Negative AND Neutral Aspheric Monofocal Intraocular Lenses
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT07385014: Completed NA study, sponsored by Milton S. Hershey Medical Center.
NCT07385014 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07385014, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the binocular distance, intermediate, and near visual acuity and patient reported outcomes of the Johnson \&Johnson Eyhance and Bausch \& Lomb enVista IOLs. We hypothesize that the Johnson \& Johnson's Eyhance and Bausch \& Lomb enVista IOLs will have similar distance, intermediate, and near visual acuity.
Primary Outcome
Mean logMAR best-distance corrected visual acuity at intermediate (66 cm) tested in binocular photopic conditions at 1 month (binocular DCIVA).
Interventions
- DEVICE Neutral Aspheric Monofocal IOL
- DEVICE Negative Aspheric Monofocal IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2023-07-27 |
| Est. Completion | 2025-10-24 |
| Phase | NA |
What the finished NCT07385014 record still lists
NCT07385014 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Neutral Aspheric Monofocal IOL is the first listed.
NCT07385014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07385014 about?
NCT07385014 is a clinical study titled "Multicenter, Double-arm, Patient AND Assessor-masked, Prospective, Randomized Clinical Trial TO Compare Visual Performance OF Negative AND Neutral Aspheric Monofocal Intraocular Lenses". The purpose of this study is to compare the binocular distance, intermediate, and near visual acuity and patient reported outcomes of the Johnson \&Johnson Eyhance and Bausch \& Lomb enVista IOLs. We hypothesize that the Johnson \& Johnson's Eyhance and Bausch \& Lomb enVista IOLs will have similar...
What is the current status of trial NCT07385014?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2023-07-27. Estimated completion is 2025-10-24.
What interventions are being tested in trial NCT07385014?
The interventions under investigation include: Neutral Aspheric Monofocal IOL (DEVICE), Negative Aspheric Monofocal IOL (DEVICE).
Who is sponsoring clinical trial NCT07385014?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07385014's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI